KEMRI/CDC Research and Public health collaboration
The Center for Disease Control and Prevention (CDC) has been collaborating with Kenyan institutions since 1979, including the Ministry of Health, Kenya Medical Research Institute (KEMRI), and non-governmental institutions.
Initially focused on malaria, activities have expanded beyond the CDC’s Division of Parasitic Diseases and now involve seven CDC Centers, including collaboration on building Kenyan institutional capacity to implement programs, conduct surveillance, and do research related to HIV/AIDS, emerging infectious diseases, tuberculosis, influenza, malaria, diarrhea, refugee health, viral hemorrhagic fevers, and health systems capacity building.
As a U.S. Government partner in the President’s Emergency Plan for AIDS Relief (PEPFAR), a large portion of CDC-Kenya’s financial contributions to Kenya supports the expansion of HIV/AIDS prevention, care and treatment programs through over 80 implementing partners.
KEMRI/CDC is involved in EACCR to build the capacity of other collaborating institutions in the conduct of clinical trials and research in the following diseases areas: HIV, malaria and tuberculosis. To this end KEMRI/CDC is currently extending several training programmes in HIV, malaria and tuberculosis laboratory training to the network partners. In addition it will make available the following general courses to the EACCR members: Good Clinical Practice (GCP), research ethics, biostatistics, data management, media training, and leadership and management trainings.
KEMRI/CDC is working closely with other partners in the EACCR to develop and implement a reciprocal monitoring programme that will lead to huge savings in terms of cost to monitoring and auditing of clinical trials within the network as compared to commercial monitors who are very expensive, as well as strong capacity building.